[1] Jaeger MB, Miná CS, Alves S, Schuh GJ, Wender MC, Manfro GG. Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause. Braz J Psychiatry. 2021 May-Jun;43(3):277-284. doi: 10.1590/1516-4446-2020-0871. PMID: 33053044; PMCID: PMC8136388.
[2] https://www.nimh.nih.gov/health/topics/anxiety-disorders
[3] https://www.nimh.nih.gov/health/topics/anxiety-disorders
[3a] Mathis MA, Alvarenga Pd, Funaro G, Torresan RC, Moraes I, Torres AR, Zilberman ML, Hounie AG. Gender differences in obsessive-compulsive disorder: a literature review. Braz J Psychiatry. 2011 Dec;33(4):390-9. doi: 10.1590/s1516-44462011000400014. PMID: 22189930.
[5] American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596
[6] https://adaa.org/sites/default/files/GAD-7_Anxiety-updated_0.pdf
[7] https://www.medicalnewstoday.com/articles/317552#anxiety-and-menopause
[8] https://www.menopause.org/for-women/menopauseflashes/menopause-symptoms-and-treatments/going-mad-in-perimenopause-signs-and-solutions
[9] Thurston RC, Joffe H. Vasomotor symptoms and menopause: findings from the Study of Women’s Health across the Nation. Obstet Gynecol Clin North Am. 2011 Sep;38(3):489-501. doi: 10.1016/j.ogc.2011.05.006. PMID: 21961716; PMCID: PMC3185243.
[10] Gorman JM. Comorbid depression and anxiety spectrum disorders. Depress Anxiety. 1996-1997;4(4):160-8. doi: 10.1002/(SICI)1520-6394(1996)4:4<160::AID-DA2>3.0.CO;2-J. PMID: 9166648.
[11] Masakazu Terauchi,Shiro Hiramitsu, Mihoko Akiyoshi Yoko Owa, Kiyoko Kato
Satoshi Obayashi,Eisuke Matsushima,Toshiro Kubota (2012) Associations between anxiety, depression and insomnia in peri- and post-menopausal women. Maturitas Volume 72, Issue 1, pg 61-65.:https://doi.org/10.1016/j.maturitas.2012.01.014
[13] https://www.womenspreventivehealth.org/recommendations/screening-for-anxiety/
[13a] https://www.healthline.com/health/cbt-techniques
[14] https://www.nimh.nih.gov/health/topics/anxiety-disorders#part_2225
[15] https://www.zrtlab.com/blog/archive/impact-hormones-serotonin-depression/#_edn12
[16] Rybaczyk LA, Bashaw MJ, Pathak DR, Moody SM, Gilders RM, Holzschu DL. An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology. BMC Womens Health. 2005;5:12. Published 2005 Dec 20. doi:10.1186/1472-6874-5-12
[17] Parry, Barbara L. MD Towards improving recognition and management of perimenopausal depression, Menopause: April 2020 – Volume 27 – Issue 4 – p 377-379
doi: 10.1097/GME.0000000000001519
[18] Maki, Pauline M. PhD1; Freeman, Ellen W. PhD2; Greendale, Gail A. MD3; Henderson, Victor W. MD, MS4; Newhouse, Paul A. MD5; Schmidt, Peter J. MD6; Scott, Nelda F. MD7; Shively, Carol A. PhD8; Soares, Claudio N. MD, PhD, FRCP9 Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition, Menopause: July 2010 – Volume 17 – Issue 4 – p 815-822
doi: 10.1097/gme.0b013e3181d763d2
[19] https://www.zrtlab.com/blog/archive/mood-menopause-perimenopause
[20] Wise, D., Felker, A., & Stahl, S. (2008). Tailoring Treatment of Depression for Women Across the Reproductive Lifecycle: The Importance of Pregnancy, Vasomotor Symptoms, and Other Estrogen-Related Events in Psychopharmacology. CNS Spectrums, 13(8), 647-662. doi:10.1017/S1092852900013742